Ligand Pharmaceuticals Statistics
Total Valuation
BKR has a market cap or net worth of $43.20 billion. The enterprise value is $46.15 billion.
| Market Cap | 43.20B |
| Enterprise Value | 46.15B |
Important Dates
The last earnings date was Tuesday, July 22, 2025, after market close.
| Earnings Date | Jul 22, 2025 |
| Ex-Dividend Date | Aug 5, 2025 |
Share Statistics
BKR has 985.88 million shares outstanding. The number of shares has decreased by -1.04% in one year.
| Current Share Class | 985.88M |
| Shares Outstanding | 985.88M |
| Shares Change (YoY) | -1.04% |
| Shares Change (QoQ) | -0.80% |
| Owned by Insiders (%) | 0.14% |
| Owned by Institutions (%) | 98.80% |
| Float | 983.59M |
Valuation Ratios
The trailing PE ratio is 14.31 and the forward PE ratio is 17.83. BKR's PEG ratio is 1.84.
| PE Ratio | 14.31 |
| Forward PE | 17.83 |
| PS Ratio | 1.57 |
| Forward PS | 1.56 |
| PB Ratio | 2.44 |
| P/TBV Ratio | 5.42 |
| P/FCF Ratio | 19.95 |
| P/OCF Ratio | 12.64 |
| PEG Ratio | 1.84 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.87, with an EV/FCF ratio of 21.32.
| EV / Earnings | 15.14 |
| EV / Sales | 1.67 |
| EV / EBITDA | 9.87 |
| EV / EBIT | 13.09 |
| EV / FCF | 21.32 |
Financial Position
The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.34.
| Current Ratio | 1.41 |
| Quick Ratio | 0.77 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 1.09 |
| Debt / FCF | 2.79 |
| Interest Coverage | 10.16 |
Financial Efficiency
Return on equity (ROE) is 18.36% and return on invested capital (ROIC) is 9.68%.
| Return on Equity (ROE) | 18.36% |
| Return on Assets (ROA) | 5.85% |
| Return on Invested Capital (ROIC) | 9.68% |
| Return on Capital Employed (ROCE) | 13.45% |
| Revenue Per Employee | $484,368 |
| Profits Per Employee | $53,474 |
| Employee Count | 57,000 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 4.24 |
Taxes
In the past 12 months, BKR has paid $244.00 million in taxes.
| Income Tax | 244.00M |
| Effective Tax Rate | 7.33% |
Stock Price Statistics
The stock price has increased by +22.61% in the last 52 weeks. The beta is 0.92, so BKR's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | +22.61% |
| 50-Day Moving Average | 39.90 |
| 200-Day Moving Average | 41.15 |
| Relative Strength Index (RSI) | 59.48 |
| Average Volume (20 Days) | 8,987,032 |
Short Selling Information
The latest short interest is 25.59 million, so 2.60% of the outstanding shares have been sold short.
| Short Interest | 25.59M |
| Short Previous Month | 24.31M |
| Short % of Shares Out | 2.60% |
| Short % of Float | 2.60% |
| Short Ratio (days to cover) | 3.46 |
Income Statement
In the last 12 months, BKR had revenue of $27.61 billion and earned $3.05 billion in profits. Earnings per share was $3.06.
| Revenue | 27.61B |
| Gross Profit | 5.92B |
| Operating Income | 3.53B |
| Pretax Income | 2.72B |
| Net Income | 3.05B |
| EBITDA | 4.68B |
| EBIT | 3.53B |
| Earnings Per Share (EPS) | $3.06 |
Balance Sheet
The company has $3.09 billion in cash and $6.03 billion in debt, giving a net cash position of -$2.95 billion or -$2.99 per share.
| Cash & Cash Equivalents | 3.09B |
| Total Debt | 6.03B |
| Net Cash | -2.95B |
| Net Cash Per Share | -$2.99 |
| Equity (Book Value) | 17.87B |
| Book Value Per Share | 17.96 |
| Working Capital | 5.10B |
Cash Flow
In the last 12 months, operating cash flow was $3.42 billion and capital expenditures -$1.25 billion, giving a free cash flow of $2.17 billion.
| Operating Cash Flow | 3.42B |
| Capital Expenditures | -1.25B |
| Free Cash Flow | 2.17B |
| FCF Per Share | $2.20 |
Margins
Gross margin is 21.42%, with operating and profit margins of 12.77% and 11.04%.
| Gross Margin | 21.42% |
| Operating Margin | 12.77% |
| Pretax Margin | 12.05% |
| Profit Margin | 11.04% |
| EBITDA Margin | 16.93% |
| EBIT Margin | 12.77% |
| FCF Margin | 7.84% |
Dividends & Yields
This stock pays an annual dividend of $0.92, which amounts to a dividend yield of 2.10%.
| Dividend Per Share | $0.92 |
| Dividend Yield | 2.10% |
| Dividend Growth (YoY) | 8.43% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 29.38% |
| Buyback Yield | 1.04% |
| Shareholder Yield | 3.14% |
| Earnings Yield | 7.06% |
| FCF Yield | 5.01% |
Analyst Forecast
The average price target for BKR is $50.83, which is 16.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $50.83 |
| Price Target Difference | 16.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 2.06% |
| EPS Growth Forecast (5Y) | 3.39% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 27, 1980. It was a forward split with a ratio of 2:1.
| Last Split Date | May 27, 1980 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
BKR has an Altman Z-Score of 2.12 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.12 |
| Piotroski F-Score | 5 |